SciLifeLab joins EATRIS – opening up for international collaborations

It’s official: SciLifeLab is becoming a member of the European Infrastructure for Translational Medicine (EATRIS). This membership will facilitate improved collaboration opportunities between SciLifeLab’s infrastructure and EATRIS’s extensive network in Europe.

With this membership, EATRIS’s international network will become accessible to researchers at SciLifeLab, and vice versa for European researchers who wish to utilize SciLifeLab’s infrastructure. It’s a promising symbiosis.

”I foresee great opportunities with the EATRIS membership for the SciLifeLab infrastructure since we will be much more visible on the European research arena which in turn could open up for interactions with new user communities and possibilities to be involved in international grant applications and consortia,” says SciLifeLab infrastructure coordinator Lars Johansson.

For the benefit of all researchers in Sweden

In addition to SciLifeLab, the membership will also bring benefits to all researchers in Sweden. Currently, not everyone is familiar with EATRIS. However, the idea is that SciLifeLab can help raise awareness of the opportunities through its networks.

“It’s an opportunity to make the national research community more aware of the expertise that EATRIS possesses. But also, to disseminate the competence and research infrastructure that already exists within SciLifeLab to researchers and businesses in Europe,” says Ulrika Bäckman, national coordinator for EATRIS Sweden.

With this membership, researchers within SciLifeLab and in Sweden can benefit from the following:

  • Access to the right expertise and research infrastructure to support projects in drug development
  • Reaching out to new users by making Swedish research infrastructure accessible
  • Opportunities for increased funding within Swedish research through participation in EATRIS consortia in larger EU calls
  • Engaging leading Swedish academic research centers to support the development of new drugs
  • Participating in EATRIS’s international educational or career development programs in translational medicine
  • Access to EATRIS’s international research infrastructure network and expert competence in translational medicine
  • Promoting Swedish research infrastructure on an international stage
  • Utilizing the Swedish node for access to 150+ institutes across Europe

Read our previous article on the coordination of EATRIS Sweden

Curious about EATRIS? Learn more on their website


Last updated: 2024-04-30

Content Responsible: victor kuismin(